Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.
Press releases published on August 13, 2025
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight
GlobeNewswire
·
August 13, 2025
New York, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight The rising demand for structural heart devices is largely …
Global Embolic Protection Devices Market Set to Experience Unprecedented Growth at a CAGR of ~8% by 2032 | DelveInsight
GlobeNewswire
·
August 13, 2025
New York, USA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global Embolic Protection Devices Market Set to Experience Unprecedented Growth at a CAGR of ~8% by 2032 | DelveInsight The demand for embolic protection devices is growing due to several important factors, …
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
GlobeNewswire
·
August 13, 2025
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8: …
Erdem Hospital Performs First-of-Its-Kind Spinal Revision Surgery
GlobeNewswire
·
August 13, 2025
Photo: Erdem Hospital via FL Communications ISTANBUL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Erdem Hospital has announced the successful completion of a first-of-its-kind spinal revision surgery, restoring mobility to a 50-year-old Italian patient after years …
Muscular Endurance: Bodybuilders Choose CrazyBulk Bodybuilding Supplements For Peak Performance & Strength Building
GlobeNewswire
·
August 13, 2025
In competitive bodybuilding, muscular endurance can be the deciding factor between finishing strong or hitting an early wall. While strength defines how much weight you can lift, endurance determines how long you can sustain intense training without …
Cook County Health Named Recipient of Scholarship Program from Joint Commission and the National Association for Healthcare Quality
GlobeNewswire
·
August 13, 2025
OAKBROOK TERRACE, Illinois, Aug. 13, 2025 (GLOBE NEWSWIRE) -- As part of the strategic alliance between Joint Commission and the National Association for Healthcare Quality (NAHQ) to improve global healthcare, the organizations announce today the …
Grady Health System Named Recipient of Scholarship Program from Joint Commission and the National Association for Healthcare Quality
GlobeNewswire
·
August 13, 2025
OAKBROOK TERRACE, Illinois, Aug. 13, 2025 (GLOBE NEWSWIRE) -- As part of the strategic alliance between Joint Commission and the National Association for Healthcare Quality (NAHQ) to improve global healthcare, the organizations announce today the …
Jackson Health System Health Named Recipient of Scholarship Program from Joint Commission and the National Association for Healthcare Quality
GlobeNewswire
·
August 13, 2025
OAKBROOK TERRACE, Illinois, Aug. 13, 2025 (GLOBE NEWSWIRE) -- As part of the strategic alliance between Joint Commission and the National Association for Healthcare Quality (NAHQ) to improve global healthcare, the organizations announce today the …
Natural Weight Loss Supplements: How PhenQ Became the Leading Alternative to Anti-Obesity Injections in 2025
GlobeNewswire
·
August 13, 2025
London, UK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PhenQ leads 2025 with a multi-action, science-informed approach to weight loss - no needles, no prescriptions, just clean, sustainable natural weight management that fits real life. In 2025, the conversation …
National Healthcareer Association Launches New Membership Community Platform
GlobeNewswire
·
August 13, 2025
LEAWOOD, Kan., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The National Healthcareer Association (NHA), the largest allied health certification agency in the United States, today announced the launch of its NHA Membership Program Community platform, an initiative …
Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
GlobeNewswire
·
August 13, 2025
Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of four (4) PET-CT 64-slice scanners to a nationally …
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
GlobeNewswire
·
August 13, 2025
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug Administration ( …
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy
GlobeNewswire
·
August 13, 2025
Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cells CHICAGO , Aug. 13, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical …
ZyVersa Therapeutics Reports Second Quarter 2025 Financial Results and Highlights Key Near-term Value-building Milestones
GlobeNewswire
·
August 13, 2025
KEY HIGHLIGHTS First clinical site for Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease (DKD) was activated June 2025; patient screening is underway, with interim results expected ~Q4-2025. IND- …
Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 13, 2025
– Initiated Phase 2 Seabreeze STAT asthma and COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations – – Presented positive data at ATS 2025 and EAACI 2025 supporting the potential of rademikibart to deliver differentiated …
Dogwood Therapeutics Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
- Enrollment to-date of 52 patients in the ongoing Halneuron® Phase 2b Trial - - Halneuron® Chemotherapy-Induced Neuropathic Pain (“CINP”) Phase 2b study interim data readout remains on track for Q4 2025 - - Low discontinuation rate (5.8%) due to adverse …
24/7 Market News: LIXTE Biotechnology Holdings Embraces Cryptocurrency in Corporate Treasury Strategy
GlobeNewswire
·
August 13, 2025
DENVER, Aug. 13, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that LIXTE Biotechnology Holdings (Nasdaq: LIXT), a clinical-stage …
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers
GlobeNewswire
·
August 13, 2025
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers Post hoc analysis published in Advances in Wound Care, provides clinical evidence supporting wound bed …
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for Primary Sjögren's Disease with Telitacicept, a Dual BAFF/APRIL Inhibitor
GlobeNewswire
·
August 13, 2025
Phase 3 results position telitacicept as potential best-in-disease profile in primary Sjögren's disease Telitacicept demonstrated a favorable safety profile Vor evaluating timing of global Phase 3 clinical study in primary Sjögren's disease Data …
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
GlobeNewswire
·
August 13, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases …